Earnings growth estimates have been revised downward across the world’s public companies for several months, most significantly in Emerging Markets (EM). See Figure 1. Despite this overall earnings weakness, the signal that the Active Quantitative Equity (AQE) team uses to capture earnings forecast revisions has performed well in helping pick market outperformers in the last three months (except in China, where it has not added value). The AQE Earnings and Revenue Trend Indicator complements the signals from our core Value, Quality, and Sentiment themes.
Figure 1: 2022 EPS Growth Estimates
%, in USD terms
Developed Market Revisions
The strongest revisions to earnings growth estimates right now are Banks in Europe and Australia, Consumer Services, Household Products, and Media stocks in Europe, and Consumer Durables and Retailing stocks in Japan. Japanese Tech Hardware and Pharmaceuticals are also seeing more favorable earnings conditions.
Among segments with strong earnings revisions, we see overall attractiveness in European and Australian Banks, and in Japanese Tech Hardware and Pharmaceuticals (see Figure 2). However, despite some positive revisions relative to other segments, European Household Products are not attractive overall because our Value signal finds them to be very expensive versus other parts of the market. Similarly, Japanese Consumer Durables are not attractive because of weak Quality and Sentiment measures.
Figure 2: Developed Market Earnings Revisions
The weakest earnings revision trends are in the US, especially in Consumer stocks (Durables, Household Products, and Autos) as well as Materials, Semiconductors, and Pharmaceuticals. US Household Products are expensive and have weak Sentiment, even though they score well on Quality measures. US Consumer Durables are very cheap, but their Quality and Sentiment measures are weak. US Materials are very weak on Sentiment. US Autos have poor measures across all AQE themes.
We do, however, have a constructive view of US Pharmaceuticals, even though their earnings revisions are weak. Sentiment and Quality metrics are quite strong on average, and US Pharmaceuticals are reasonably priced versus other market segments.
US Semiconductors’ earnings revisions are weak (with supply chain issues denting near-term earnings), but measures of Quality and Sentiment remain strong, driven by ongoing demand dynamics.
Emerging Markets Revisions
In China, Banks have delivered weak earnings revisions and Semiconductor firms have delivered strong earnings revisions. Across the rest of EM, the exact opposite is true, with Banks delivering strong earnings revisions and Semiconductor firms delivering weak earnings revisions. Figure 3 details the more complete picture of why we see overall attractiveness in all EM Banks and Semiconductors.
Figure 3: EM Banking and Semiconductor Sectors
The Bottom Line
Even though earnings forecasts have weakened in recent months, we believe that it is important to pay attention to other attributes when selecting stocks. Value and Quality are important themes to consider, along with key Sentiment measures (e.g., price sentiment, hedge fund positioning, supply-chain linkages, and conference call sentiment).
For use in EMEA: The information contained in this communication is not a research recommendation or ‘investment research’ and is classified as a ‘Marketing Communication’ in accordance with the Markets in Financial Instruments Directive (2014/65/EU) or applicable Swiss regulation. This means that this marketing communication (a) has not been prepared in accordance with legal requirements designed to promote the independence of investment research (b) is not subject to any prohibition on dealing ahead of the dissemination of investment research.
This communication is directed at professional clients (this includes eligible counterparties as defined by the appropriate EU regulator) who are deemed both knowledgeable and experienced in matters relating to investments. The products and services to which this communication relates are only available to such persons, and persons of any other description (including retail clients) should not rely on this communication.
Important Risk Information
Investing involves risk including the risk of loss of principal.
The information provided does not constitute investment advice and it should not be relied on as such. It should not be considered solicitation to buy or an offer to sell a security. It does not take into account any investor’s particular investment objectives, strategies, tax status or investment horizon. You should consult your tax and financial advisor.
All information is from SSGA unless otherwise noted and has been obtained from sources believed to be reliable, but its accuracy is not guaranteed. There is no representation or warranty as to the current accuracy, reliability or completeness of, nor liability for, decisions based on such information and it should not be relied on as such.
This document contains certain statements that may be deemed forward-looking statements. Please note that any such statements are not guarantees of any future performance and actual results or developments may differ materially from those projected. Investing involves risk including the risk of loss of principal.
The views expressed are the views of Active Quantitative Equity through November 7, 2022, and are subject to change based on market and other conditions.
Quantitative investing assumes that future performance of a security relative to other securities may be predicted based on historical economic and financial factors, however, any errors in a model used might not be detected until the fund has sustained a loss or reduced performance related to such errors.
Equity securities may fluctuate in value and can decline significantly in response to the activities of individual companies and general market and economic conditions.
Actively managed funds do not seek to replicate the performance of a specified index. An actively managed strategy may underperform its benchmarks. An investment in the strategy is not appropriate for all investors and is not intended to be a complete investment program. Investing in the strategy involves risks, including the risk that investors may receive little or no return on the investment or that investors may lose part or even all of the investment.
Investing in foreign domiciled securities may involve risk of capital loss from unfavorable fluctuation in currency values, withholding taxes, from differences in generally accepted accounting principles or from economic or political instability in other nations. Investments in emerging or developing markets may be more volatile and less liquid than investing in developed markets and may involve exposure to economic structures that are generally less diverse and mature and to political systems which have less stability than those of more developed countries.
The trademarks and service marks referenced herein are the property of their respective owners.
This information is for informational purposes only, not to be construed as investment advice or a recommendation or offer to buy or sell any security. Investors should always obtain and read an up-to-date investment services description or prospectus before deciding whether to appoint an investment manager or to invest in a fund. Any views expressed herein are those of the author(s), are based on available information, and are subject to change without notice. Individual portfolio management teams may hold different views and may make different investment decisions for different clients. There are no guarantees regarding the achievement of investment objectives, target returns, portfolio construction, allocations or measurements such as alpha, tracking error, stock weightings and other information ratios. The views and strategies described may not be suitable for all investors. SSGA does not provide tax or legal advice. Prospective investors should consult with a tax or legal advisor before making any investment decision. Investing entails risks and there can be no assurance that SSGA will achieve profits or avoid incurring losses.
Performance quoted represents past performance, which is no guarantee of future results. Investment return and principal value will fluctuate, so you may have a gain or loss when shares are sold. Current performance may be higher or lower than that quoted.
Images of NYSE Group, Inc. are used with permission of NYSE Group, Inc. Neither NYSE Group, Inc. nor its affiliated companies sponsor, approve of or endorse the contents of this program. Neither NYSE Group, Inc. nor its affiliated companies recommend or make any representation as to possible benefits from any securities or investments.